Key result
Rosuvastatin and ezetimibe effectively lower LDL cholesterol to prevent atherosclerotic cardiovascular disease.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
SAEtAK: Aterosklerotske kardiovaskularne bolesti (ASCVD) globalan su javnozdravstveni izazov s potencijalno fatalnim posljedicama.Kljuni imbenik u prevenciji ASCVD-a jest kontrola razine LDL kolesterola (LDL-C).
No takes yet. Share an insight, caveat, or question.
Aleksandar Trbović (2023) studied this question. Rosuvastatin and ezetimibe are effective pharmacological therapies for lowering elevated LDL cholesterol to prevent atherosclerotic cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: